Atlas Trials

Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer

Clinical trial NCT00132756 · TERMINATED

Trial details

NCT number
NCT00132756
Sponsor
Morton Plant Mease Health Care
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2003-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.